Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      USFDA approves Vercise Deep Brain Stimulation System from Boston Scientific

      USFDA approves Vercise Deep Brain Stimulation System from Boston Scientific

      Ruby Khatun Khatun31 Dec 2017 10:00 AM IST
      MARLBOROUGH: Boston Scientific Corporation announced that it has received approval from the U.S. Food and Drug Administration (FDA) for the Vercise™...
      Updated Obamacare enrollment figure dips to 8.7 million

      Updated Obamacare enrollment figure dips to 8.7 million

      Ruby Khatun Khatun31 Dec 2017 9:30 AM IST
      About 8.7 million people enrolled in healthcare plans for 2018 using the federal Obamacare marketplace, according to updated government figures...
      USFDA nod for Zydus Pharmaceuticals OCD treatment drug

      USFDA nod for Zydus Pharmaceuticals OCD treatment drug

      Ruby Khatun Khatun30 Dec 2017 11:00 AM IST
      New Delhi: Zydus Pharmaceuticals (USA) Inc has received final approval from the US health regulator to market Clomipramine Hydrochloride capsules,...
      Brazil gives nod for Mylan-Biocons breast cancer biosimilar trastuzumab 

      Brazil gives nod for Mylan-Biocon's breast cancer biosimilar trastuzumab 

      Ruby Khatun Khatun30 Dec 2017 10:30 AM IST
      New Delhi: Drug major Biocon and Mylan's proposed biosimilar trastuzumab has been approved by Brazilian regulatory agency ANVISA, through their...
      Changing labels to sell Expired Drugs: Govt Cancels Licenses of Mahalaxmi Traders

      Changing labels to sell Expired Drugs: Govt Cancels Licenses of Mahalaxmi Traders

      Ruby Khatun Khatun30 Dec 2017 10:28 AM IST
      PATNA: Licenses of Mahalaxmi Traders' has cancelled by the state health department for the trading of expired drugs after a supplementary...
      Plea against patent for pneumonia vaccine filed by Panacea Biotec

      Plea against patent for pneumonia vaccine filed by Panacea Biotec

      Ruby Khatun Khatun30 Dec 2017 10:01 AM IST
      New Delhi: Drug firm Panacea Biotec has filed a review petition against the grant of a patent with regard to a pneumonia vaccine to the US-based...
      Marketing of device to treat diabetic foot ulcers permitted by FDA

      Marketing of device to treat diabetic foot ulcers permitted by FDA

      Ruby Khatun Khatun30 Dec 2017 10:00 AM IST
      The U.S. Food and Drug Administration (FDA) permitted the marketing of the Dermapace System, the first shock wave device intended to treat diabetic...
      Gene therapy finds a place in medicine, 2017 memorable year

      Gene therapy finds a place in medicine, 2017 memorable year

      Ruby Khatun Khatun30 Dec 2017 9:30 AM IST
      After decades of hope and high promise, this was the year scientists really showed they could doctor DNA to successfully treat diseases. Gene...
      Lupin moves High Court fearing tax on pre-GST stock

      Lupin moves High Court fearing tax on pre-GST stock

      Ruby Khatun Khatun29 Dec 2017 12:34 PM IST
      Mumbai: Lupin has filed a writ petition in Delhi High Court against the Government of India claiming the stock lying in its godowns could face double...
      USFDA gives nod to Lupin generic psoriasis treatment solution

      USFDA gives nod to Lupin generic psoriasis treatment solution

      Ruby Khatun Khatun29 Dec 2017 11:00 AM IST
      New Delhi: Pharma major Lupin Ltd said it has received final approval from the US health regulator for its generic version of Dovonex scalp solution...
      Patanjali to enter diaper and sanitary napkin market

      Patanjali to enter diaper and sanitary napkin market

      Ruby Khatun Khatun29 Dec 2017 10:30 AM IST
      After making headway into several markets, Patanjali Ayurveda is now eyeing the diaper and sanitary napkin industry, to take on the international...
      Pharma cos revenues to grow 9 percent over next 3 yrs

      Pharma cos revenues to grow 9 percent over next 3 yrs

      Ruby Khatun Khatun29 Dec 2017 10:00 AM IST
      Mumbai: Robust domestic demand and rising need for complex products in the West will help domestic pharma players log in a 9 percent revenue growth...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok